Related Experiment Video

Updated: May 1, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
08:35

Examining BCL-2 Family Function with Large Unilamellar Vesicles

Published on: October 5, 2012

7.4K

BH3-only proteins: possible proapoptotic triggers for melanoma therapy

Michael Plötz1, Jürgen Eberle

  • 1Department of Dermatology, Venerology and Allergology, HTCC - Skin Cancer Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Experimental Dermatology
|March 29, 2014
PubMed

Insights

Targeted melanoma therapies like BRAF inhibitors often fail due to resistance. Combining these drugs with BH3 mimetics, which trigger apoptosis, could improve treatment outcomes by overcoming resistance mechanisms.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Melanoma treatments, including BRAF inhibitors and immune therapies, face frequent tumor relapse within a year.
  • Therapy resistance in melanoma is often linked to defects in proapoptotic signaling pathways.
  • The balance of pro- and antiapoptotic Bcl-2 proteins critically regulates apoptosis in melanoma cells.

Purpose of the Study:

  • To investigate the role of BH3-only proteins in melanoma apoptosis.
  • To explore the potential of combining BRAF inhibitors with BH3 mimetics for improved melanoma therapy.

Main Methods:

  • Analysis of proapoptotic signaling defects in melanoma.
  • Investigating the function of BH3-only proteins, such as Bim, in melanoma.
  • Evaluating the efficacy of combining BRAF inhibitors with BH3 mimetics.

Main Results:

  • BH3-only proteins act as key proapoptotic triggers in melanoma.
  • The proapoptotic effects of BRAF inhibitors are dependent on BH3-only proteins like Bim.
  • Knockdown of Bim prevents the proapoptotic effects of BRAF inhibitors.

Conclusions:

  • Efficient induction of apoptosis is a primary therapeutic goal for melanoma.
  • BH3 mimetics, which mimic BH3-only proteins, show promise for cancer therapy.
  • Combining BRAF inhibitors with BH3 mimetics may significantly enhance melanoma treatment by overcoming resistance.
Keywords:
BRAFBcl-2 homology domain 3Bcl-2 proteinsBimapoptosismelanoma

More Related Videos

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics12:28

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on: January 11, 2019

6.5K
A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

18.1K

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K